Physician profile
Tracie Bryson
NPI 1982698288
$927.41
in general payments reported to CMS, 2019-2025
19 companies · $99.76 in 2025
The $99.76 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2021: $153 · 2022: $129 · 2023: $129 · 2024: $125 · 2025: $99.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.71 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $126.25 | 2019-2024 | Zepbound, Taltz, Olumiant |
| Abbvie INC. | $108.06 | 2019-2024 | Rinvoq |
| Ucb, INC. | $98.84 | 2023-2025 | Bimzelx, Cimzia |
| Dermira, INC. | $87.52 | 2019 | |
| Janssen Biotech, INC. | $79.99 | 2021 | |
| Pfizer INC. | $57.15 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $53.96 | 2024-2025 | |
| Incyte Corporation | $49.23 | 2021-2022 | |
| Leo Pharma INC. | $40.10 | 2022-2025 | Anzupgo |
| Sun Pharmaceutical Industries INC. | $38.50 | 2019-2021 | |
| Arcutis Biotherapeutics, INC. | $35.38 | 2024 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $32.25 | 2019 | |
| Biofrontera INC. | $19.53 | 2019 | |
| Glaxosmithkline, LLC. | $17.81 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $17.17 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $17.03 | 2024 | |
| Botanix Sb INC | $17.02 | 2025 | Sofdra |
| Medimetriks Pharmaceuticals, INC. | $16.53 | 2019 | |
| Almirall LLC | $15.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracie Bryson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.